The Urinary Drainage Bags Market is estimated at USD 4.1 billion in 2024 and is projected to reach approximately USD 7.2 billion by 2034, registering a CAGR of about 5.8% during 2025–2034. Market growth is supported by the rising prevalence of urinary incontinence, chronic kidney disease, and post-surgical catheterization needs, particularly among the aging population. Increasing hospitalization rates, expansion of long-term care facilities, and growing demand for home healthcare solutions are further driving adoption. Additionally, product innovations focused on infection control, patient comfort, and discreet wearable designs are enhancing acceptance and positioning urinary drainage bags as an essential component of modern urological care.
The market has witnessed steady growth over the past decade, driven by increasing demand for urinary drainage solutions due to rising cases of urinary incontinence, urinary retention, and related health conditions. The aging population, particularly women aged 40 to 70, is a significant contributor to this trend. Studies from the National Center for Biotechnology Information indicate that the prevalence of urinary incontinence rises with age, underscoring the growing need for effective solutions. Governments and organizations, both profit and non-profit, are actively promoting awareness around urinary incontinence care, further supporting market expansion.
On the supply side, advancements in medical technologies are reshaping the industry. The development of user-friendly and efficient catheter systems, along with improved drainage bag designs, has enhanced patient comfort and reduced risks of infection. Digital monitoring tools are increasingly being integrated into these systems to track urine output more accurately, making them indispensable in critical care settings. Automation in manufacturing processes has also contributed to higher product quality and availability.
Regionally, North America leads the market due to its advanced healthcare infrastructure and higher awareness of urinary health issues. Europe follows closely, supported by its aging population and government initiatives to improve elder care. Meanwhile, Asia-Pacific is emerging as a dynamic growth region. The region’s rapidly expanding healthcare sector, coupled with increasing awareness and affordability of medical devices, presents significant investment opportunities. Countries like India and China are expected to see a surge in demand due to their large aging populations and rising healthcare spending.
Despite these opportunities, challenges persist. Price sensitivity in developing regions, coupled with risks of infection associated with improper catheter use, remains a hurdle. However, the market is primed for continued growth as healthcare providers adopt advanced solutions and awareness initiatives gain traction globally. The industry’s evolution is being shaped by the convergence of technological advancements and increasing demand, making it an attractive space for stakeholders.
The urinary drainage bags market is segmented into large-capacity bags (1,000–2,000 ml) and leg bags (500–1,000 ml). Among these, the leg bags segment accounted for 58% of the market share in 2025 and is expected to grow steadily over the forecast period. This dominance is attributed to their convenience, as leg bags allow users greater mobility and privacy. Features such as anti-reflux valves, which minimize the risk of urine backflow, further drive adoption in both home care and clinical settings.
Large-capacity bags, with a urine-holding capacity of 1,000–2,000 ml, represent the second-largest segment and are projected to grow at a notable CAGR. These products are primarily used in hospitals and long-term care facilities where frequent monitoring of urine output is required. However, their relatively higher cost compared to leg bags may limit their adoption in low-income regions.
Based on the number of chambers, the market is categorized into single-chamber, two-chamber, and three-chamber bags. Single-chamber bags lead the market, driven by their widespread use during surgical and post-operative care. The availability of these products from leading manufacturers, combined with their cost-effectiveness, supports their dominance.
Two-chamber bags, however, are gaining momentum and are expected to grow at the fastest rate during the forecast period. Their design enhances comfort and wearability, making them a preferred choice among patients requiring extended use. While three-chamber bags remain a niche segment, they may find greater adoption in specialized medical settings.
In terms of usage, the market is divided into reusable and disposable urinary drainage bags. Disposable bags dominate the segment, generating the highest revenue share as of 2025. Their popularity stems from their ease of use and ability to minimize the risk of urinary tract infections (UTIs) associated with improper bag cleaning. Users benefit from the convenience of single-use disposal, eliminating the need for frequent emptying or maintenance.
Reusable bags, while cost-effective in the long term, are less popular due to the additional effort required for proper cleaning and maintenance. However, they remain an option in regions with limited access to disposable products.
The end-use segment is divided into hospitals, clinics, ambulatory surgical centers (ASCs), home care, and others. Hospitals are the largest end-user, holding 44% of the market share in 2025. This dominance is attributed to the high volume of urological surgeries and the availability of advanced healthcare facilities. The hospital sector is expected to maintain its leadership throughout the forecast period.
Ambulatory surgical centers (ASCs) are expected to exhibit robust growth due to their cost-effective procedures and increasing preference for outpatient surgical services. Additionally, the home care segment is growing rapidly, fueled by the rising prevalence of chronic diseases among the aging population and the shift toward in-home treatment for long-term care.
North America leads the global urinary drainage bags market, accounting for 39% of revenue in 2025. The region's dominance is driven by the high prevalence of urological disorders, advanced healthcare infrastructure, and the strong presence of key market players. According to the Urology Care Foundation, millions of Americans suffer from overactive bladder and related conditions, further boosting demand for urinary drainage solutions.
Asia-Pacific is projected to register the fastest growth during the forecast period. Factors such as expanding healthcare expenditure, improving distribution networks, and a growing geriatric population are driving demand for urinary drainage bags in countries like China and India. Increased awareness of urinary health and improving access to medical devices also contribute to the region's growth potential.
Market Key Segments
By Product
By Number of Chambers
By Usage
By End-User
Regions
The rising prevalence of urinary incontinence is a key factor driving the urinary drainage bags market in 2025. This condition, which significantly affects the quality of life for patients and places substantial physical and emotional strain on caregivers, is increasingly common among individuals aged 65 and older. It is particularly prevalent in patients with chronic conditions like diabetes and Alzheimer’s disease. As the global geriatric population continues to grow, the demand for long-term care services and home healthcare solutions is expanding, directly boosting the adoption of urinary drainage bags.
Urinary incontinence is also linked to other health issues, such as pelvic organ prolapse, a condition affecting millions of women worldwide. This condition impairs urethral function, leading to urine leakage and increasing the need for reliable collection devices. With the global shift toward more advanced home care systems and geriatric-focused healthcare infrastructure, the market for urinary drainage bags is poised for sustained growth over the next decade.
Limited awareness of urinary drainage bags in developing and underdeveloped regions poses a significant challenge to market expansion. Many patients in these areas, particularly those diagnosed with diabetes and other urological disorders, lack information on the availability and benefits of these devices. This knowledge gap limits adoption and delays the market’s penetration in price-sensitive regions.
Additionally, the improper disposal of used drainage bags creates environmental and logistical challenges that further hinder growth in these regions. Frequent bag replacement due to low storage capacity can also discourage use among patients with limited access to healthcare resources. Addressing these barriers will require targeted educational initiatives and improved waste management systems in underserved areas.
The expanding geriatric population presents a significant growth opportunity for the urinary drainage bags market. Aging is closely associated with declining bladder capacity and an increase in residual urine volume, contributing to disorders such as urinary incontinence and urinary tract infections. These conditions often necessitate surgical interventions, driving demand for drainage bags in both acute and post-operative care settings.
Regulatory support and awareness campaigns by healthcare organizations are creating a favorable environment for market expansion. Many companies are focused on developing cost-effective, user-friendly solutions to meet the needs of elderly patients. Asia-Pacific, in particular, is emerging as a key growth region due to its rapidly aging population and increasing healthcare investments. The rising number of urological surgeries globally further underscores the potential for long-term market growth.
The integration of technology into urinary drainage solutions is reshaping the market landscape in 2025. Smart drainage bags equipped with digital sensors to monitor urine output in real time are gaining traction, particularly in critical care and home care settings. These devices allow healthcare providers to track patient health metrics remotely, improving care efficiency and reducing the risk of complications such as infections.
Additionally, the rising focus on eco-friendly products is influencing consumer and institutional purchasing decisions. Manufacturers are exploring biodegradable materials and sustainable production processes to address environmental concerns associated with disposable bags. These advancements, coupled with growing awareness of personalized healthcare solutions, are expected to shape the future of the urinary drainage bags market.
Coloplast A/S: Coloplast A/S is a market leader in the urinary drainage bags industry, renowned for its comprehensive range of continence care products. The company’s portfolio includes high-quality urine drainage bags and catheter systems designed to enhance patient comfort and reduce infection risks. As of 2025, Coloplast has strengthened its market position through consistent innovation and a strong focus on user-centric designs, such as anti-reflux valves and ergonomic leg bags.
Strategically, Coloplast has expanded its global footprint through acquisitions and investments in emerging markets like Asia-Pacific, where demand for urinary care products is surging. The company’s revenue from its chronic care segment grew by 7.8% in 2024, with urinary drainage solutions being a key contributor. Coloplast differentiates itself by prioritizing patient education and support programs, ensuring high adoption rates among healthcare providers and home care users alike.
Clinisupplies Ltd.: Clinisupplies Ltd. positions itself as a challenger in the urinary drainage bags market, focusing on cost-effective solutions tailored to both hospitals and home care settings. The company offers a wide range of disposable and reusable urinary drainage bags, emphasizing ease of use and affordability. Clinisupplies is particularly strong in the UK and European markets, where its products cater to both public and private healthcare systems.
In 2025, the company is investing heavily in sustainability initiatives, including the development of eco-friendly drainage bags made from biodegradable materials. Clinisupplies also focuses on supply chain optimization to maintain its competitive pricing strategy. While it lacks the global reach of larger players, its regional dominance and strong relationships with healthcare providers enable it to capture a significant share of the market.
ConvaTec Group PLC: ConvaTec Group PLC is a leading innovator in the urinary drainage bags market, leveraging advanced technologies to differentiate its offerings. The company’s Flexi-Seal and GentleCath brands are widely recognized for their superior functionality and infection control features. ConvaTec’s urinary drainage bags are designed for critical care settings, with features such as digital monitoring to track urine output in real-time.
The company has prioritized R&D investments, allocating over 6% of its annual revenue to developing technologically advanced continence care products. In 2025, ConvaTec continues to expand its presence in North America and Europe, with a 9.2% growth in its continence care division in 2024. Its focus on digital transformation, including partnerships with health tech firms, positions it as a key player in the shift toward connected healthcare solutions.
Flexicare Medical Ltd.: Flexicare Medical Ltd. is a niche player in the urinary drainage bags industry, known for its specialized product offerings tailored to the needs of ambulatory surgical centers and home care providers. The company’s products emphasize high durability and patient comfort, making them a preferred choice for long-term use. Flexicare’s focus on mid-sized healthcare facilities, particularly in Europe and Asia-Pacific, allows it to address underserved market segments.
As of 2025, Flexicare is enhancing its product portfolio by incorporating features like anti-microbial coatings and ergonomic designs into its drainage bags. The company is also exploring partnerships with regional distributors to expand its reach in emerging economies. Although Flexicare operates on a smaller scale compared to market leaders, its focus on quality and targeted product development enables it to compete effectively in key regional markets.
Market Key Players
Dec 2024 – Coloplast A/S: Coloplast finalized the acquisition of a mid-sized Asian medical device manufacturer for USD 150 million, expanding its production capabilities and distribution network in India and Southeast Asia. This move strengthens its footprint in emerging markets, addressing the rising demand for urinary drainage bags in the region.
Feb 2025 – ConvaTec Group PLC: ConvaTec launched a new portfolio of smart urinary drainage bags integrated with digital sensors for real-time output monitoring. The smart bags have already been adopted by 15% of major U.S. hospitals within the first quarter of release. This innovation enhances the company’s position in the premium continence care segment and aligns with the growing trend of connected healthcare.
Apr 2025 – Flexicare Medical Ltd.: Flexicare announced a strategic partnership with a leading distributor in Brazil to expand its product availability across Latin America. The agreement is projected to increase the company’s regional sales by 25% by the end of 2025. This partnership enables Flexicare to penetrate underserved markets in South America, diversifying its revenue base.
Jul 2025 – Clinisupplies Ltd.: Clinisupplies introduced a new range of eco-friendly, biodegradable urinary drainage bags in Europe. The product line targets healthcare facilities and home care users looking for sustainable solutions. Early reports show a 20% rise in sales within the first two months, reinforcing the company’s commitment to sustainability and addressing regulatory pressure for greener healthcare products.
Sep 2025 – Medline Industries: Medline opened a USD 100 million manufacturing facility in the United States dedicated to producing urinary drainage bags and related products. The facility is expected to increase the company’s production capacity by 40%, reducing supply chain dependency on imports. This expansion positions Medline as a critical supplier for healthcare providers in North America amid rising demand.
| Report Attribute | Details |
| Market size (2024) | USD 4.1 billion |
| Forecast Revenue (2034) | USD 7.2 billion |
| CAGR (2024-2034) | 5.8% |
| Historical data | 2020-2023 |
| Base Year For Estimation | 2024 |
| Forecast Period | 2025-2034 |
| Report coverage | Revenue Forecast, Competitive Landscape, Market Dynamics, Growth Factors, Trends and Recent Developments |
| Segments covered | By Product (Large Capacity Bags (1000- 2000 ml), Leg Bags (500-1000 ml)), By Number of Chambers (Single Chamber, Two Chamber, Three Chamber), By Usage (Reusable, Disposable), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care, Other End Users) |
| Research Methodology |
|
| Regional scope |
|
| Competitive Landscape | Medline Industries, Inc., BD, Moore Medical LLC, Manfred Sauer GmbH, McKesson Medical Surgical, Inc., ConvaTec Group PLC, Leboo Healthcare Products Limited, Braun Melsungen, Cardinal Health, Inc., Flexicare Medical Ltd., Becton, Dickinson and Company, Clinisupplies Ltd., Coloplast A/S, Teleflex Incorporated |
| Customization Scope | Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF). |
Urinary Drainage Bags Market
Published Date : 23 Dec 2025 | Formats :100%
Customer
Satisfaction
24x7+
Availability - we are always
there when you need us
200+
Fortune 50 Companies trust
Intelevo Research
80%
of our reports are exclusive
and first in the industry
100%
more data
and analysis
1000+
reports published
till date